Proposed rule will create significant, retroactive reporting requirements for private payor payment rates to clinical laboratories.
Many clinical laboratories will need to expend significant resources to track, collect...more
In the wake of a new Medicare reimbursement framework, FDA plans stricter regulation of some in vitro diagnostic devices.
On July 31, 2014, the U.S. Food and Drug Administration (FDA; Agency) announced its intent to...more
CMS will begin to enforce what could be significant penalties on manufacturers who fail to report required data.
The Centers for Medicare & Medicaid Services (CMS) has announced a short timeframe before detailed...more
The Centers for Medicare & Medicaid Services (CMS) has initiated a new review process of existing national coverage determinations (NCDs). This new process is designed to retire old policies and may present increased risks to...more
CMS’s August 2013 notice establishes a new internal review process, signalling increased agency-initiated activity -
The Centers for Medicare & Medicaid Services (CMS or the Agency) has initiated an automatic,...more